Blog
3 Value Stocks for Sharp Investors
Finding a value stock isn't always as easy as just screening for stocks with low price-to-earnings ratios -- although that's a good place to start. Sharp investors know that sometimes, there's more to
These 3 Stocks Have Lost Over 50% in 2017
Wall Street has been riding high on record performance for major market benchmarks, extending the eight-year-old bull market in 2017. Not every stock has participated in the overall rally, however
How to Deal With That One Co-Worker
We all have that one co-worker who makes an otherwise pleasant office environment perpetually intolerable. If you're dealing with a co-worker who's pretty much making you hate your job, here are a few
1 More Potential Explanation for Intel Corporation's Core X Supply-Demand Imbalance
I recently wrote about the apparent supply-to-demand imbalance of Intel's (NASDAQ: INTC) eight- and 10-core Core X processors for the high-end desktop market. In short, demand seems to be outstripping
Will Social Security Go Up in 2018?
Countless Americans rely on Social Security to stay afloat financially in retirement. But for years, enrollees have been struggling to keep up with their living costs. The Senior Citizens League
Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter
Pfizer (NYSE: PFE) stands at the top of the mountain when it comes to prescription drug sales. Last year, the big pharma company made $45.9 billion from prescription drugs, well ahead of runners-up
Volaris Stock Has Surged 39% Since February: Here's Why It Could Keep Rising
Between the spring of 2016 and February 2017, shares of Mexican ultra-low-cost carrier Volaris (NYSE: VLRS) lost nearly half of their value as unit revenue came under pressure and the weak peso drove
Is 2018 the Year Virtual Reality Goes Mainstream?
Facebook's (NASDAQ: FB) Oculus is reportedly planning to release a stand-alone virtual reality device next year to retail for just $200. The goal is to push VR into the mainstream.Virtual reality has
Why Five Below Inc. Stock Gained 22% in 2017 So Far
Five Below (NASDAQ: FIVE) stock gained 22% through the first half 2017, according to data provided by S&P Global Market Intelligence.The retailer's shares even traded over $50 for just the third time
Will Check Point Software’s Q2 Results Keep Investor Confidence Up?
Shares of Check Point Software Technologies (NASDAQ: CHKP) have been on a tear this year, rising more than 33% thanks to impressive quarterly performances and the growing demand for cybersecurity
Some Days, the Business World Is Full of Surprises
On this Market Foolery podcast, host Mac Greer is joined by Motley Fool Total Income's Ron Gross and Million Dollar Portfolio's Matt Argersinger to discuss several notable items and what they mean for
Can Square Keep Going After Last Week's 12% Pop?
We may never know if Huey Lewis was right about being hip to be square, but it's certainly been hip to be a Square (NYSE: SQ) shareholder these days. Shares of the high-tech transactions enabler hit
Do You Need $1 Million to Retire? Maybe.
When we talk about saving for retirement, we tend to throw around the $1 million figure as a target to aim for. Why $1 million? Perhaps people are drawn to that number because it's nice and round, and
Surprise! Lockheed Martin's "Expensive" F-35 Now Costs Less than a Boeing F/A-18
Give President Trump his due.Late last year, the then-president elect blasted Lockheed Martin (NYSE: LMT) for charging taxpayers a "tremendous cost" for its F-35 stealth fighter jet. At the time
Can Fitbit Inc. Regain Its Mojo?
Back in Sep. 2015, I predicted that Fitbit (NYSE: FIT) would drop from the $30s back to its IPO price of $20. That happened just a few months later, but the stock subsequently dropped another 70% to
3 Things to Watch in the Stock Market This Week
Stocks reached record highs last week, with both the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) gaining more than 1%. The two indexes are each showing returns
Better Buy: Biogen Inc. vs. Celgene Corporation
Biogen (NASDAQ: BIIB) and Celgene (NASDAQ: CELG) have ranked among the most successful biotech stocks of the past decade. Biogen stock has soared more than 430% in the last 10 years, while Celgene's
Will the "First State" Be the Next to Legalize Recreational Marijuana in Early 2018?
Unless you've been living under a rock, you're probably well aware of the blazing quick growth pace of the legal marijuana industry -- as well as why investors have been gravitating to marijuana
How NVIDIA Makes Most of Its Money -- and Why the Mix Is Changing Rapidly
NVIDIA (NASDAQ: NVDA) stock is one-upping an '80s hit tune: Rather than raining mere men, it's raining money. The graphics-chip specialist's stock has returned 52.9% in 2017 through July 12
How to Invest in Gold Stocks: 3 Options You Should Consider
Gold has attracted interest for millennia, and even today, investors like the idea of a physical store of value that can protect against the inflationary pressures that periodically plague monetary
Social Security's Reserves Grew by $35 Billion in 2016 -- So Why Is the Program in Trouble?
According to the just-released 2017 Social Security Trustees' report, Social Security brought in $35 billion more than it paid out, and now has a whopping $2.85 trillion in reserves in the OASDI Trust
These 3 Charts Don't Lie: Gilead Sciences Needs an Acquisition
Pretty much everyone familiar with Gilead Sciences (NASDAQ: GILD) wants the company to make an acquisition. Many think the big biotech desperately needs one (or more) to reenergize the lethargic
4 Ways Trumpcare Could Decimate Medicaid
Change is in the air on Capitol Hill -- or at least Republican lawmakers would like you to think so.When Donald Trump was elected president and Republicans retained their majority in Congress, the
Roundtable: 1 Stock I'm Never Selling
Stocks that are worth buying and holding for exceptionally long periods of time are far less common than most investors may think. Changes in underlying market conditions, after all, can knock even
5 Top Commodity ETFs
Investing in commodities can be extremely difficult for ordinary investors. Many commodities aren't tradeable in physical form in any practical sense, and even those that are can involve storage costs